Literature DB >> 18826373

Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.

Myron J Levin1, Roberta L DeBiasi, Vanda Bostik, D Scott Schmid.   

Abstract

A previously healthy boy who had received varicella vaccine developed herpes zoster with meningitis. The vaccine strain recovered from scabs of 3 skin lesions had the wild-type allele at position 108111, a vaccine marker never previously associated with vaccine-associated adverse events. The vaccine strain from cerebrospinal fluid also contained mutations never previously observed at vaccine-associated single nucleotide polymorphisms that would alter amino acid sequences in ORF54 and ORF59. The presence of distinct strains in skin lesions and cerebrospinal fluid indicate that >1 variant strain may reactivate to cause herpes zoster.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18826373     DOI: 10.1086/592452

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  A Toddler With Rash, Encephalopathy, and Hemolytic Anemia.

Authors:  Christiana Smith; Cullen Dutmer; D Scott Schmid; Megan K Dishop; William J Bellini; Erwin W Gelfand; Edwin J Asturias
Journal:  J Pediatric Infect Dis Soc       Date:  2015-05-28       Impact factor: 3.164

2.  Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.

Authors:  Mark L Quinlivan; Nancy J Jensen; Kay W Radford; D Scott Schmid
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

3.  Vaccine Oka Varicella Meningitis in Two Adolescents.

Authors:  Whitney E Harrington; Sayonara Mató; Lauri Burroughs; Paul A Carpenter; Anne Gershon; D Scott Schmid; Janet A Englund
Journal:  Pediatrics       Date:  2019-12       Impact factor: 7.124

4.  Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine.

Authors:  Barbara A Pahud; Carol A Glaser; Cornelia L Dekker; Ann M Arvin; D Scott Schmid
Journal:  J Infect Dis       Date:  2010-12-21       Impact factor: 5.226

5.  Perspectives on vaccines against varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 6.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 7.  Neurovirulence of varicella and the live attenuated varicella vaccine virus.

Authors:  Corey Horien; Charles Grose
Journal:  Semin Pediatr Neurol       Date:  2012-09       Impact factor: 1.636

Review 8.  Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.

Authors:  Catherine Amlie-Lefond; Don Gilden
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-04-29       Impact factor: 2.136

Review 9.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

10.  Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity.

Authors:  Kimberly D Tran; Michelle M Falcone; Daniel S Choi; Raquel Goldhardt; Carol L Karp; Janet L Davis; Anat Galor
Journal:  Ophthalmology       Date:  2016-04-08       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.